0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Sperm recovery from urine in men with retrograde ejaculation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Retrograde ejaculation (RE) consists of the reflux backwards, towards the bladder, of the ejaculate, during the emission phase of ejaculation, causing a total or partial absence of sperm emission, with the consequent diversion of semen into the bladder during the emission phase of ejaculation. Evaluating the ejaculate may not be sufficient for identifying RE in some patients. Hence, the management of infertility may involve the use of invasive methods such as epididymal fluid retrieval or testicular biopsy.

          Content

          This paper defines RE and methods for its diagnosis. A description is also provided of the techniques used for the detection of sperm in post-ejaculatory urine (PEU), the preparation and retrieval of sperm from urine and their subsequent use in assisted reproductive techniques.

          Summary

          The diagnosis of RE is based on the detection of spermatozoa in PEU in patients with aspermia or oligozoospermia and low or normal seminal volume. Although the presence of sperm in PEU could be sufficient for a diagnosis of RE, there is a lack of consensus regarding the diagnostic criteria for PEU, and the literature available is very limited. A correct diagnosis of RE allows the use of PEU for recovering sperm and its subsequent use in assisted human reproduction techniques, thus avoiding invasive techniques.

          Outlook

          A significant number of patients with RE may remain undiagnosed. Therefore, it is essential to conduct an RE study in patients with suspicion, through the analysis of PEU, and to properly interpret the results for accurate diagnosis.

          Related collections

          Most cited references84

          • Record: found
          • Abstract: not found
          • Article: not found

          Physiology and Pharmacology of Ejaculation

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Serotonin and premature ejaculation: from physiology to patient management.

            Premature ejaculation (PE), whose pathophysiology is still not clearly identified, is the most common male sexual dysfunction, yet it remains underdiagnosed and undertreated. The aims of this paper are to provide a scientific and pharmacologic rationale, and to discuss to what extent selective serotonin reuptake inhibitors (SSRIs) can help patients with PE. A comprehensive evaluation of available published data included analysis of published full-length papers that were identified with Medline and Cancerlit from January 1981 to January 2006. Official proceedings of internationally known scientific societies held in the same time period were also assessed. The central ejaculatory neural circuit comprises spinal and cerebral areas that form a highly interconnected network. The sympathetic, parasympathetic, and somatic spinal centers, under the influence of sensory genital and cerebral stimuli integrated and processed at the spinal cord level, act in synergy to command physiologic events occurring during ejaculation. Experimental evidence indicates that serotonin (5-HT), throughout brain descending pathways, exerts an inhibitory role on ejaculation. To date, three 5-HT receptor subtypes (5-HT1A, 5-HT1B, and 5-HT2C) have been postulated to mediate 5-HT's modulating activity on ejaculation. Pharmacologic manipulation of the serotonergic system has been performed in rats, with the antidepressant selective serotonin reuptake inhibitors (SSRIs) exhibiting the greatest efficacy in delaying ejaculation. The mechanism of action by which SSRIs modulate central 5-HT tone has been studied in depth, but gaps in this knowledge prevent an explanation of the efficacy of acute treatment in delaying ejaculation. Emerging clinical evidence indicates chronic and on-demand dosing of SSRIs has a beneficial effect for the treatment of men with PE, at least for paroxetine. On-demand dapoxetine, and SSRI with a short half-life, recently has been shown to significantly increase intravaginal latency time and PE patient-related outcomes in phase 3 clinical trials. Nowadays there is no doubt that PE can be treated effectively by SSRIs. Nevertheless their mechanism of action is not yet well understood and deserves more research. In particular it is not understood why all the SSRIs are not equal in terms of their ability to delay ejaculation. Therefore, there is a need for more research to better characterize the mechanism of action of SSRIs as well their clinical benefit in patients affected by PE.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus: a prospective, controlled study.

              Retrograde ejaculation (RE) and erectile dysfunction may be caused by diabetes mellitus (DM), but the prevalence of RE among DM patients is unknown. A prospective, blinded case-control study comparing men with DM with matched controls according to RE and erectile dysfunction was performed. Twenty-seven men with DM matched the inclusion criteria and agreed to participate in the study, and of these 26 delivered an ejaculate. We were able to recruit 18 matching controls, and of these 16 delivered an ejaculate. Nine of 26 men with DM who delivered an ejaculate had RE, whereas none of 16 controls had RE (p < 0.01). The mean duration of DM was longer for DM patients with RE (20 years) compared with DM patients in whom RE could not be demonstrated (13 years), but the difference was not statistically significant. RE could not be associated with BMI, waist circumference, blood pressure, Haemoglobin A1c (HgbA1c), high-density lipoprotein HDL cholesterol, triglycerides, fasting glucose, or s-testosterone. Diabetics suffering from RE more frequently exhibited erectile dysfunction compared with non-diabetics and diabetics without RE, and the last-mentioned group again more frequently than controls. These findings could not be explained by use of antihypertensive drugs. Whereas none of the included control participants showed signs of abnormal ejaculation, every third man with DM exhibited retrograde ejaculation. It is important to be aware of this association, and that post-ejaculatory urine is routinely analysed from aspermic fertility clinic attendants and diabetics with low ejaculate volumes.
                Bookmark

                Author and article information

                Contributors
                Journal
                Adv Lab Med
                Adv Lab Med
                almed
                almed
                Advances in Laboratory Medicine
                De Gruyter
                2628-491X
                22 August 2024
                December 2024
                : 5
                : 4
                : 356-365
                Affiliations
                Working Group on Andrology and Assisted Reproduction Technologies, Spanish Society of Laboratory Medicine (SEQCML), , Barcelona, Spain
                deptAssisted Human Reproduction Unit, Central Laboratory , universityUniversity Clinical Hospital of Santiago de Compostela , Santiago de Compostela, Spain
                deptLaboratory of Assisted Reproduction, Service of Biochemistry . universityAlcorcón Foundation University Hospital , Calle Budapest, 1, 28922 Alcorcón, Madrid, Spain
                deptLaboratory of Assisted Reproduction, Service of Biochemistry , universityPuerta del Mar University Hospital , Cadiz, Spain
                deptLaboratory of Assisted Reproduction and Andrology, Service of Clinical Biochemistry, Vall d’Hebron Clinical Laboratories , universityVall d’Hebron University Hospital , Pg. de la Vall d’Hebron, 119, 08035, Barcelona, Spain
                deptLaboratory of Assisted Reproduction, UGC of Maternal Fetal Medicine, Genetics and Reproduction, Women’s Hospital , universityVirgen del Rocío University Hospital , Avda. Manuel Siurot s/n, 41013, Sevilla, Spain
                deptLaboratory of Andrology and Assisted Reproduction, Service of Biochemistry , universityWomen’s Hospital, La Paz University Hospital , Paseo de la Castellana 261, 28046, Madrid, Spain
                deptLaboratory of Assisted Reproduction and Andrology, Service of Clinical Biochemistry, Vall d’Hebron Clinical Laboratories , universityVall d’Hebron University Hospital , Pg. de la Vall d’Hebron, 119, 08035, Barcelona, Spain
                deptLaboratory of Assisted Reproduction and Andrology. Service of Biochemistry . universityVirgen de Valme University Hospital , Avda. Bellavista s/n, 41014, Sevilla, Spain
                deptVanesa Castañón Bernardo, Laboratory of Assisted Reproduction . universityCentral University Hospital of Asturias . Avda. Roma s/n. 33011 Oviedo, Spain
                deptLaboratory of Assisted Reproduction; UCG Clinical Analysis . universityReina Sofía University Hospital . Avenida Menéndez Pidal s/n 14004, Córdoba, Spain
                Author notes
                Corresponding author: Ernesto Veiga Álvarez, deptWorking Group on Andrology and Assisted Reproduction Technologies, Spanish Society of Laboratory Medicine (SEQCML) , Barcelona, Spain; and deptAssisted Human Reproduction Unit, Central Laboratory , universityUniversity Clinical Hospital of Santiago de Compostela , Travesía da Choupana s/n, CP 15706, Santiago de Compostela, Spain, E-mail: ernesto.veiga.alvarez@ 123456sergas.es
                All authors are members of the SEQC ML working group on Andrology and Assisted Reproduction Technologies. A SEQC ML working group.
                Author information
                https://orcid.org/0000-0002-0883-2448
                https://orcid.org/0000-0002-4118-2774
                Article
                almed-2024-0109
                10.1515/almed-2024-0109
                11704877
                dd064a16-900c-4f47-8d37-6e3d158c7acf
                © 2024 the author(s), published by De Gruyter, Berlin/Boston

                This work is licensed under the Creative Commons Attribution 4.0 International License.

                History
                : 26 June 2024
                : 10 May 2024
                Page count
                Figures: 01, Tables: 03, References: 84, Pages: 10
                Categories
                Review

                aspermia,azoospermia,ejaculation,male infertility,semen,sexual dysfunction

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content46

                Most referenced authors638